Ocimum gratissimum (African Basil)

African basil (Ocimum gratissimum) contains high concentrations of flavonoids including apigenin (12.36%) and luteolin (9.06%) alongside rosmarinic acid (3.82%). These phenolic compounds demonstrate antioxidant activity through free radical scavenging and potential anti-inflammatory mechanisms.

Origin & History

Ocimum gratissimum, commonly known as African basil, is a perennial herb native to tropical Africa and Asia that belongs to the Lamiaceae (mint) family. The plant's leaves are processed into extracts, powders, or essential oils through methods including solvent extraction, steam distillation, and drying.

Historical & Cultural Context

The research does not provide information about traditional medicine systems that have used Ocimum gratissimum or specific historical applications. Additional sources would be needed to document its traditional use context.

Health Benefits

• Contains diverse phytochemicals including flavonoids (luteolin 9.06%, apigenin 12.36%) and phenylpropanoids (rosmarinic acid 3.82%) - evidence quality: chemical analysis only
• Rich in phenolic compounds and antioxidants including quercetin and epicatechin - evidence quality: phytochemical profiling only
• Source of volatile essential oils containing monoterpenoids like carvacrol (0.20-8.40%) - evidence quality: chemical composition data only
• Contains alkaloids, saponins, and tannins traditionally associated with medicinal properties - evidence quality: phytochemical screening only
• Provides fatty acids including palmitic acid (28.35%) and methyl acetate (30.55%) - evidence quality: chemical analysis only

How It Works

African basil's bioactive compounds work through multiple antioxidant pathways. Apigenin and luteolin act as flavonoid antioxidants by donating electrons to neutralize free radicals and potentially modulating inflammatory signaling cascades. Rosmarinic acid contributes additional phenolic antioxidant activity through similar electron-donating mechanisms.

Scientific Research

The research dossier does not contain specific human clinical trials, randomized controlled trials, meta-analyses, or PubMed PMIDs for Ocimum gratissimum. While antimicrobial and antifungal activities are referenced, no detailed clinical trial data with sample sizes or human outcome measures are provided.

Clinical Summary

Current evidence for African basil is limited to phytochemical analysis and chemical profiling studies. Research has identified significant concentrations of bioactive flavonoids (apigenin 12.36%, luteolin 9.06%) and phenylpropanoids (rosmarinic acid 3.82%) through laboratory analysis. No human clinical trials have been conducted to establish therapeutic efficacy or optimal dosing. Additional research including animal studies and human trials is needed to validate traditional uses and safety profiles.

Nutritional Profile

{"macronutrients": {"protein": "Not extensively quantified", "fiber": "Not extensively quantified"}, "micronutrients": {"vitamins": "Not extensively quantified", "minerals": "Not extensively quantified"}, "bioactive_compounds": {"flavonoids": {"luteolin": "9.06%", "apigenin": "12.36%"}, "phenylpropanoids": {"rosmarinic_acid": "3.82%"}, "phenolic_compounds": {"quercetin": "Concentration not specified", "epicatechin": "Concentration not specified"}, "volatile_essential_oils": {"monoterpenoids": {"carvacrol": "0.20-8.40%"}}}, "bioavailability_notes": "The bioavailability of these compounds can vary based on preparation methods and individual metabolism."}

Preparation & Dosage

No clinically studied dosage ranges are available in the research for any form of Ocimum gratissimum (extract, powder, or standardized preparations). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other Ocimum species, rosemary, oregano, thyme, turmeric

Safety & Interactions

Safety data for African basil supplementation is limited due to lack of clinical research. As with other Ocimum species, potential interactions with anticoagulant medications may occur due to phenolic compound content. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with bleeding disorders or those taking blood-thinning medications should consult healthcare providers before use.